Dale Bredesen
Alzheimer's Prevention and Reversal Project, Inc.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Dale Bredesen as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:34 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05894954 · Precision Medicine Approach for Early Dementia & Mild Cognitive ImpairmentAlzheimer's Prevention and Reversal Project, Inc. · completed · Mild Cognitive Impairment, Dementia, Mild · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 19 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:34 UTC. The ranking covers the 200 most relevant of 3 PubMed records, and a shared surname and initials can bring in a namesake. All 3 on PubMed
- Reversal of cognitive decline: a novel therapeutic program.Aging (Albany NY) · 2014121 citationsRCR 4.4
- 70 citationsRCR 1.9
- Precision Medicine Approach to Alzheimer's Disease: Successful Pilot Project.J Alzheimers Dis · 202255 citationsRCR 4.6